Management of acne with emesis procedure by using Dhamargava as drug

Efficacy of Vaman Karma with Dhamargava in Mukhadushika (Acne Vulgaris) - Nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/03/063847

Enrollment

Registered

2024-03-08

Start date

Unknown

Completion date

Unknown

Last updated

2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L700- Acne vulgaris Health Condition 2: L989- Disorder of the skin and subcutaneous tissue, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients of Age group 18 - 34 years of either sex are included. 2.Patients fit for Vamana Krama 3.Patients will be selected with signs and symptoms of Mukhdaushika (Acne Vulgaris) Viz comedones, Papules, Postules and Nodules

Exclusion criteria

Exclusion criteria: 1.Patients contraindicated for Vaman Karma. 2.Pregnant Women and lactating mother 3.Patient suffering from secondary skin disease e.g. psoriasis on face, Vitiligo. 4.Patients with current or past one month use of long-term steroid therapy or any medication. 5.Known patients of psychological disorder, diabetes and hypertension. 6.Patients with evidence of ren al, hepatic and cardiac involvement.

Design outcomes

Primary

Measure	Time frame
Reduction in signs and symptoms of Acne vulgaris Timepoint: Base line, 15th day, 30th day	—

Secondary

Measure	Time frame
Improvement in Global Acne Grading System Timepoint: Base line, 15th day, 30th day	—

Countries

India

Contacts

Public ContactDr Manjula V Matekar

Bharati vidyapeeth college of Ayurved

manju.matekar@bharatividyapeeth.edu9890254424

Outcome results